First Friday Biosciences: Dec 1 in Beverly
Full Title: From cocoon to silk: Transformation lessons from an early-stage biotech start-up
Speaker: Dr. Ailis Tweed-Kent, CEO of Cocoon Biotech
Online Registration: While walk-ins are always welcomed, advance registration is appreciated – please note: the charge for all walk-ins in $15
Who better to learn from about the importance of capital efficiency, building a team and network, and out of the box financing strategies for early-stage biotech companies, than from one of the Boston Business Journals 2017 Women to Watch in Science and Technology winners? Dr. Ailis Tweed-Kent, CEO of Cocoon Biotech promises to share her best secrets and anecdotes of success.
About Cocoon Biotech
Cocoon Biotech, Inc. was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide. Cocoon Biotech is developing a drug-delivery platform based on formulations of fibroin, a protein derived from the cocoon of the silkworm (Bombyx mori). Silk fibroin is a biocompatible protein that has been used for decades as a suture material; however, recent advances in our understanding of fibroin biochemistry has allowed expansion of the versatility of the material into alternate physical formats such as spheres and hydrogels loaded with active drug substances.
Cocoons first product is silk fibroin formulated with a small molecule that targets pain and inflammation. Cocoon is leveraging silk fibroin as a novel biomaterial for the stability and delivery of therapeutics across human health and animal health.
100 Cummings Center, Suite 221-E
Beverly MA USA
Date and Time
Begins: 12/01/2017 12:30 PM
Ends: 12/01/2017 02:00 PM
Dr. Ailis Tweed-Kent, CEO of Cocoon Biotech
Dr. Ailis Tweed-Kent is an up-and-coming entrepreneur and leader in the development of innovative medical technologies. With her education in medicine at Harvard Medical School (HMS) and residency in internal medicine at Massachusetts General Hospital (MGH), Ailis has firsthand knowledge of the burden of disease. In 2013, Ailis was inspired by her patients to found Cocoon to develop innovative silk therapeutics for osteoarthritis. Prior to Cocoon, she worked on the design, development, and delivery of diagnostic technologies for global health collaborating with organizations such as PEPFAR/Office of U.S. Global AIDS Coordinator, London School of Hygiene & Tropical Medicine, and the Global Health Delivery Project. She brings a multidisciplinary approach with a B.S. in Chemical Engineering from the University of Notre Dame.
Registration, networking and lunch start at 12:30; Program
begins at 1 p.m.
See Who Has Registered:
To see who has registered for this event,
Online registration closes at 5 p.m. the day before this event. While walk-ins are never turned away, advance registration helps the team and is greatly appreciated.
Please note: There is a $15 charge for all walkins.
Pizza, salad, and soft drinks will be served.
Add to my Outlook Calendar
Add to my iCal Calendar
Add to my Google Calendar
http://www.google.com/calendar/event?action=TEMPLATE&text=First Friday Biosciences: Dec 1 in Beverly&dates=20171201T173000Z/20171201T190000Z&sprop=null&details=Details: https://www.123signup.com/event?id=hjqrn&location=100 Cummings Center, Suite 221-E, Beverly, MA